Use of continuous glucose monitoring to improve diabetes mellitus management

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue SUPPL. 2, 2007, Pages 46-68

  Ellis, Samuel L ^a   Bookout, Tevin ^a   Garg, Satish K ^a   Izuora, Kenneth E ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE OXIDASE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ACCURACY; ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; DEVICE; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MEDICAL TECHNOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; REIMBURSEMENT; SAFETY; SENSOR;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; DIABETES MELLITUS; FORECASTING; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; LONG-TERM CARE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 41749083036     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(07)80011-9     Document Type: Article

References (38)

1. American Diabetes Association. Statistics sheet: total prevalence of diabetes and pre-diabetes (2007). http://www.diabetes.org/diabetes-statistics/prevalence.jsp Accessed July 5, 2007
2. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
3. Saydah S., Fradkin J., and Cowie C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
4. Resnick H., Foster G., Bardsley J., et al. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 29 (2006) 531-537
5. Nathan D., Buse J., Davidson M., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [published correction appears in Diabetes Care 2006;49:2816-18]. Diabetes Care 29 (2006) 1963-1972
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
7. Schiffrin A., and Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 5 (1982) 479-484
8. Nyomba B., Berard L., and Murphy L. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycaemic control: a prospective study in insulin-treated diabetic patients. Diabet Med 21 (2004) 129-135
9. Chase H., Kim L., Owen S., et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107 (2001) 222-226
10. Boland E., Monsod T., Delucia M., et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24 (2001) 1858-1862
11. McGowan K., Thomas W., and Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes [published correction appears in Diabetes Care 2003;26:553]. Diabetes Care 25 (2002) 1499-1503
12. Weintrob N., Schechter A., Benzaquen H., et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med 158 (2004) 677-684
13. Ludvigsson J., and Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 111 (2003) 933-938
14. Garg S., Zisser H., Schwartz S., et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 29 (2006) 44-50
15. Deiss D., Bolinder J., Riveline J., et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 29 (2006) 2730-2732
16. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44 (1995) 968-983
17. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
18. Kilpatrick E., Rigby A., and Atkin S. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29 (2006) 1486-1490
19. Garg S., Potts R., Ackerman N., et al. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 22 (1999) 1708-1714
20. Schiaffini R., Ciampalini P., Fierabracci A., et al. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev 18 (2002) 324-329
21. GlucoWatch Biographer. http://www.glucowatch.com Accessed July 5, 2007
22. TM STS Glucose Monitoring System. http://www.dexcom.com Accessed July 5, 2007
23. ® REAL-Time Insulin Pump and Continuous Glucose Monitoring System. http://www.minimed.com/products/insulinpumps/index.html Accessed July 5, 2007
24. ® REAL-Time Continuous Glucose Monitoring System. http://www.minimed.com/products/guardian Accessed July 5, 2007
25. ® Continuous Glucose Monitoring System. http://www.abbottdiabetescare.com/adc_dotcom/url/content/en_US/10.10:10/general_content/General_Content_0000163.htm Accessed July 5, 2007
26. Tamada J., Garg S., Jovanovic L., et al., for the Cygnus Research Team. Noninvasive glucose monitoring: comprehensive clinical results. JAMA 282 (1999) 1839-1844
27. 1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 29 (2006) 2644-2649
28. Wilson D., Beck R., Tamborlane W., et al., for the DirecNet Study Group. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 30 (2007) 59-64
29. Clarke W., Cox D., Gonder-Frederick L., et al. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 10 (1987) 622-628
30. Kovatchev B., Gonder-Frederick L., Cox D., et al. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 27 (2004) 1922-1928
31. Clarke W., Anderson S., Farhy L., et al. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 28 (2005) 2412-2417
32. Chase H., Roberts M., Wightman C., et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 111 (2003) 790-794
33. Bailey T., Zisser H., and Garg S. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 9 (2007) 203-210
34. Tanenberg R., Bode B., Lane W., et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 79 (2004) 1521-1526
35. Chico A., Vidal-Rios P., Subira M., et al. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 26 (2003) 1153-1157
36. Ellis S., Voelmle M., Gottlieb P., et al. Improved glycemic control with real-time continuous glucose sensors in patients with type 1 diabetes. Abstracts of the American Diabetes Association Diabetes 2007 Meeting, Chicago, Ill. Diabetes 56 Suppl 1 (2007) A119 (Abstract # 449-P)
37. Voelmle M., Gottlieb P., Ellis S., et al. Fetal outcomes and improved A1c values in pregnant women with type 1 diabetes using real-time continuous glucose sensors. Abstracts of the American Diabetes Association Diabetes 2007 Meeting, Chicago, Ill. Diabetes 56 Supp 1 (2007) A117 (Abstract # 440-P)
38. Garg S., Schwartz S., and Edelman S. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27 (2004) 734-738